Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 1810251 | AZD-3514 | 1240299-33-5 | >98% |  |
| AZD-3514 is a potent androgen receptor downregulator with potential anticancer cancer | ||||
| 1810223 | AZ32 | no | >98% |  |
| AZ32 is an orally bioavailable and blood-brain barrier-penetrating ATM inhibitor with | ||||
| 1810222 | ARS-1620 | 1698055-85-4 | >98% |  |
| ARS-1620 is an atropisomeric selective KRAS-G12C inhibitor with desirable pharmacokin | ||||
| 1810175 | AGL-2263 | 638213-98-6 | >98% |  |
| AGL-2263 is a novel insulin receptor inhibitor. | ||||
| 1810173 | AM211 | 1175526-27-8 | >98% |  |
| AM-211 is a novel and potent antagonist of the prostaglandin D2 receptor type 2. | ||||
| 188281 | Arimoclomol maleate | 289893-26-1 | 98% |  |
| Arimoclomol, also known as BRX-220, is potentially useful for the treatment of Nieman | ||||
| 187123 | ASP7663 | 1190217-35-6 | >98% |  |
| ASP7663 is an orally bioavailable selective TRPA1 activator. | ||||
| 187111 | Aldoxorubicin HCl | 480998-12-7 | >98% |  |
| Aldoxorubicin, also known as INNO-206 and Doxo-EMCH, is the 6-maleimidocaproyl hydraz | ||||
| 18791 | ABT 702 Dihydrochloride | 1188890-28-9 | >98% |  |
| ABT 702 Dihydrochloride is a potent non-nucleoside adenosine kinase inhibitor, select | ||||
| 18761 | Avacopan | 1346623-17-3 | >98% |  |
| Avacopan, also known as CCX168, is an orally active, selective and potent C5aR inhibi | ||||
| 18753 | AEW-541 | 475489-16-8 | >98% |  |
| AEW541, also known as NVP-AEW541, is a novel, potent IGF-IR kinase inhibitor. | ||||
| 18741 | AMD-070 HCl | 880549-30-4 | >98% |  |
| AMD11070, also known as AMD070, X4P-001 and mavorixafor, is an orally bioavailable an | ||||
| 186273 | AG-494 | 133550-35-3 | >98% |  |
| AG-494, also known as Tyrphostin AG-494, is an inhibitor of epidermal growth factor r | ||||
| 186254 | AZD5153 | 1869912-39-9 | >98% |  |
| AZD5153 is a potent bivalent triazolopyridazine based Bromodomain and Extraterminal ( | ||||
| 186252 | Amenamevir | 841301-32-4 | >98% |  |
| Amenamevir, also known as ASP2151, is a herpes virus helicase-primase inhibitor. | ||||
| 186211 | A22 hydrochloride | 22816-60-0 | >98% |  |
| A22 is an inhibitor of MreB, an actin-like bacterial protein, and has been shown to a | ||||
| 186158 | AST487 | 630124-46-8 | >98% |  |
| AST487, also known as NVP- AST487, is a RET kinase inhibitor/FLT3 inhibitor. | ||||
| 185253 | ARV-825 | 1818885-28-7 | >98% |  |
| ARV-825 is a PROTAC (proteolysis-targeting chimera). ARV-825 exerts superior lethal a | ||||
| 185222 | Alobresib | 1637771-14-2 | >98% |  |
| Alobresib is an antineoplastic drug candidate. | ||||
| 185221 | Adavivint | 1467013-03-3 | >98% |  |
| Adavivint is a Wnt pathway inhibitor and immunomodulator drug candidate. | ||||
| 185213 | ALX 1393 | 949164-09-4 | >98% |  |
| ALX 1393 is a glycine transporter-2 inhibitor. | ||||
| 185211 | A-485 | 1889279-16-6 | >98% |  |
| A-485 is a potent and selective HAT inhibitor of p300/CBP in vitro with an IC50 of 10 | ||||
| 185187 | AS-1517499 | 919486-40-1 | >98% |  |
| AS-1517499 is a potent and selective STAT6 inhibitor. | ||||
| 185185 | AMG-176 | 1883727-34-1 | >98% |  |
| AMG-176 is an inhibitor of induced myeloid leukemia cell differentiation protein MCL- | ||||
| 185183 | A-350619 HCI | 1217201-17-6 | >98% |  |
| A-350619 hydrochloride is an activator of soluble guanylyl cyclase (sGC). | ||||
| 185176 | ARQ-531 | 2095393-15-8 | >98% |  |
| ARQ-531 is a potent and orally active BTK inhibitor with potential antineoplastic act | ||||
| 185173 | ADX-47273 | 851881-60-2 | >98% |  |
| ADX-47273 is a potent and selective mGluR5 receptor PAM (positive allosteric modulato | ||||
| 18542 | AMG-511 | 1253573-53-3 | >98% |  |
| AMG-511 is a potent and selective pan class I PI3K inhibitor. | ||||
| 18541 | AZD1390 | 2089288-03-7 | >98% |  |
| AZD1390 is a potent and selective ATM inhibitor with the ability to cross the blood-b | ||||
| 1842813 | ALW-II-41-27 | 1186206-79-0 | >98% |  |
| ALW-II-41-27 is a Eph receptor tyrosine kinase inhibitor. | ||||